share_log

4: Statement of changes in beneficial ownership of securities-Officer Glover Stephen C.

4: Statement of changes in beneficial ownership of securities-Officer Glover Stephen C.

4:持股變動聲明-高管 Glover Stephen C.
美股SEC公告 ·  07/19 09:36

牛牛AI助理已提取核心訊息

Stephen C. Glover, the Chief Executive Officer of ZyVersa Therapeutics, Inc. (ZVSA), was involved in a transaction with the company's stock on May 24, 2023. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the transaction, were not disclosed in the announcement. Consequently, the number of shares held by Glover after the transaction remains unknown.
Stephen C. Glover, the Chief Executive Officer of ZyVersa Therapeutics, Inc. (ZVSA), was involved in a transaction with the company's stock on May 24, 2023. The specific details of the transaction, including the number of shares traded, the nature of the shares, the transaction price, and the total value of the transaction, were not disclosed in the announcement. Consequently, the number of shares held by Glover after the transaction remains unknown.
2023年5月24日,ZyVersa Therapeutics公司的首席執行官Stephen C. Glover參與了一項公司股票交易。在公告中未透露交易的具體細節,包括交易的股票數量、股票性質、交易價格以及交易的總價值,因此Glover在交易後持有的股票數量仍然未知。
2023年5月24日,ZyVersa Therapeutics公司的首席執行官Stephen C. Glover參與了一項公司股票交易。在公告中未透露交易的具體細節,包括交易的股票數量、股票性質、交易價格以及交易的總價值,因此Glover在交易後持有的股票數量仍然未知。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。